(Q41611766)

5 October 2017

Heparin-mediated selective release of hepatocyte growth factor in humans (English)

1 reference

5 October 2017

P B Salbach

1

1 reference

5 October 2017

M Brückmann

2

1 reference

5 October 2017

O Turovets

3

1 reference

5 October 2017

J Kreuzer

4

1 reference

5 October 2017

W Kübler

5

1 reference

5 October 2017

I Walter-Sack

6

1 reference

5 October 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

British Journal of Clinical Pharmacology

5 October 2017

1 reference

5 October 2017

50

1 reference

5 October 2017

3

1 reference

5 October 2017

221-226

1 reference

Natural hepatocyte growth factor (HGF) from human serum and a bound form of recombinant HGF with heparan sulfate are indistinguishable in their physicochemical properties

5 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

6 June 2018

HGF/SF in angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Low-molecular-weight heparins

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Heparin functions as a hepatotrophic factor by inducing production of hepatocyte growth factor

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Integral membrane heparan sulfate proteoglycans

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Heparin as an inducer of hepatocyte growth factor

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Scatter factor induces blood vessel formation in vivo

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Therapeutic uses of heparin beyond its traditional role as an anticoagulant.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Molecular cloning and expression of human hepatocyte growth factor

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Proteoglycans as modulators of growth factor activities

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Comparative effect of heparin treatment with and without strenuous exercise on treadmill capacity in patients with stable effort angina

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Recent insights into coronary collateral circulation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Collagens in the liver extracellular matrix bind hepatocyte growth factor.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014977

Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats

19 August 2018

1 reference

12 December 2020

Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes

1 reference

12 December 2020

Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: an experimental study

1 reference

12 December 2020

Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction

1 reference

12 December 2020

A vascular modulator, hepatocyte growth factor, is associated with systolic pressure

1 reference

12 December 2020

Heparin induces rapid and remarkable elevation of hepatocyte growth factor/scatter factor during trans arterial embolization of renal cell carcinoma

1 reference

12 December 2020

Serum basic fibroblast growth factor levels in patients with ischemic heart disease

1 reference

12 December 2020

Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model

1 reference

12 December 2020

Therapeutic angiogenesis: a comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin

1 reference

12 December 2020

Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease

1 reference

12 December 2020

Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group

1 reference

12 December 2020

Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis

1 reference

12 December 2020

A two-pronged approach to the clinical use of HGF

1 reference

12 December 2020

Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin

1 reference

12 December 2020

10.1111/J.1365-2125.2000.00246.X

Identifiers

DOI

1 reference

5 October 2017

1 reference

5 October 2017

PubMed publication ID

10971306

1 reference